Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
IT |
|
Sienna Resources Inc
XTSX:SIE
|
CA |
|
I
|
iRobot Corp
XMUN:I8R
|
US |
|
W
|
Waters Corp
DUS:WAZ
|
US |
|
S
|
SBI Holdings Inc
SWB:ZOF
|
JP |
|
Marimaca Copper Corp
ASX:MC2
|
CA |
|
Papoutsanis Industrial and Commercial of Consumer Goods SA
F:Y2O
|
GR |
|
Bombardier Inc
F:BBDC
|
CA |
|
Smart Parking Ltd
F:E8Q
|
AU |
|
Vital Metals Ltd
OTC:VTMXD
|
AU |
|
T
|
TomTom NV
F:OEMA
|
NL |
Wall St Price Targets
REC Price Targets Summary
Recordati Industria Chimica e Farmaceutica SpA
According to Wall Street analysts, the average 1-year price target for REC is 60.44 EUR with a low forecast of 48.48 EUR and a high forecast of 74.55 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is REC's stock price target?
Price Target
60.44
EUR
According to Wall Street analysts, the average 1-year price target for REC is 60.44 EUR with a low forecast of 48.48 EUR and a high forecast of 74.55 EUR.
What is the Revenue forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 7%.
What is the Gross Profit forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 15%.
What is the Pre-Tax Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Recordati Industria Chimica e Farmaceutica SpA?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 15%.
